| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $142.1M | $139.2M | $150.7M |
| YoY Revenue Growth % | +2.1% | -7.6% | — |
| Gross Profit | $71.5M | $75.0M | — |
| Gross Margin % | 50.3% | 53.9% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$18.0M | -$820.0K | -$33.1M |
| Operating Margin % | -12.7% | -0.6% | -22.0% |
| Net Income (GAAP) | -$21.4M | -$10.1M | -$41.5M |
| EBITDA (Normalized) | -$18.0M | -$820.0K | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $20.1M | $23.9M | $1.6M |
| Capital Expenditures (CapEx) | $17.0K | $0 | — |
| Free Cash Flow (FCF) | $20.1M | $23.9M | $1.6M |
| FCF Margin % | 14.1% | 17.1% | 1.0% |
| Return on Invested Capital (ROIC %) | -20.4% | -0.8% | — |
| Cash & Short-Term Equivalents | $63.1M | $48.8M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $132.7M | $128.2M | — |